A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy

Journal of the American Academy of Dermatology

Volumn 60, Issue 6, 2009, Pages 972-979

  Carruthers, Alastair ^a   Carruthers, Jean ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; EYEBROW HEAVINESS; EYEBROW PARALYSIS; EYELID DISEASE; EYELID LUMPY; EYELID SWELLING; EYELID WRINKLE; FEMALE; GLABELLAR SWELLING; HEADACHE; HUMAN; INCIDENCE; INJECTION SITE BLANCHING; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SKIN TIGHTNESS; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER FACIAL RHYTID; WRINKLE;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; PROSPECTIVE STUDIES; RHYTIDOPLASTY; TIME FACTORS;

EID: 65649086452     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.01.005     Document Type: Article

References (7)

1. American Society of Plastic Surgeons. 2000/2006/2007 National plastic surgery statistics, cosmetic and reconstructive procedure trends. Available from: http://www.plasticsurgery.org/media/statistics/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=29287. Accessed May 22, 2008.
2. Garcia A., and Fulton Jr. J.E. Cosmetic denervation of the muscles of facial expression with botulinum toxin: a dose-response study. Dermatol Surg 22 (1996) 39-43
3. Carruthers A., Carruthers J., and Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg 29 (2003) 461-467
4. Carruthers J.A., Lowe N.J., Menter M.A., Gibson J., Nordquist M., Mordaunt J., et al., Botox Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46 (2002) 840-849
5. Carruthers A., Carruthers J., Lowe N.J., Menter A., Gibson J., Nordquist M., et al., Botox Glabellar Lines I and II Study Groups. One-year, randomized, multicenter, two-period study of the safety and efficacy of repeated treatments with botulinum toxin type A in patients with glabellar lines. J Clin Res 7 (2004) 1-20
6. Carruthers A, Carruthers J. Long-term safety review of subjects treated with botulinum toxin type A for cosmetic use. Poster presented at: 62nd Annual Meeting of the American Academy of Dermatology; July 28-August 1, 2004; New York, NY.
7. Lowe N.J., Ascher B., Heckmann M., Kumar C., Fraczek S., Eadie N., and and the Botox Facial Aesthetics Study Team. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 31 (2005) 257-262